Bandingkan Harga & Kinerja Graha Mitra Asia Tbk. (RELF) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Graha Mitra Asia Tbk. dan Organon Pharma Indonesia Tbk.: Graha Mitra Asia Tbk. diperdagangkan di Rp37 (kapitalisasi pasar 223,39 M, volume 24 jam 6,4 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Graha Mitra Asia Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RELF | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 223,39 M | 104,4 M |
Volume | 6,4 jt | — |
Lot | 63,97 rb | — |
Perputaran | 237,95 jt | — |
Harga Rata-rata | 37,2 | — |
Nilai Transaksi | 237,95 jt | — |
Harga Ekuilibrium Indikatif | 37 | — |
Volume Ekuilibrium Indikatif | 6,03 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Graha Mitra Asia Tbk.
PT Graha Mitra Asia Tbk (hereinafter referred to as the "Company") was established based on Deed No. 15 dated 17 April 2018 issued by Notary Susi Aprilina, SH MKn. The Company started its commercial operations in 2018.
Selengkapnya di halaman RELF →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
